NYSE · CVS
CVS Health Corp.
Healthcare · Medical - Healthcare Plans
$85.05▼ 0.94% ($0.81)at close
Pre-market$85.14▲ 0.11%7:55 AM ET
Market cap
$108.52B
P/E
22.24
EPS (TTM)
$3.82
Next earnings
Nov 4, 2026
Valuation
P/E Valuation
Verdict: expensive. Price above all scenarios.
Estimated value / share · Base
$63.92
−25%Price vs. estimate range
Assumption scenarios, not confidence intervals
Bear $62.02, Base $63.92, Bull $60.67; price used $85.05
Bear $62.02, Base $63.92, Bull $60.67; price used $85.05
- P/E multiple
- 16.7×
- Earnings basis
- Trailing EPS
USD · Trailing earnings · Price Sep 24, 8:00 PM UTC
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 11.35% over the last year. Revenue grew 7.36% over the trailing twelve months. Operating margin moved from 2.32% to 2%. Free cash flow grew 145.98% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 2%. A decisive move in revenue — currently up 7.36% — would be the clearest signal to resolve the ambiguity.
Return analysis
Company profile
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services.
Market multiples
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Analyst consensus
35
Buy
6
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 4, 2026
Q4 FY26 · EPS est $1.62 · Revenue est $104.49B
View
Institutional Sentiment
CVS Health Corp. · CVS
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.